BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25552590)

  • 1. Cannabis and schizophrenia.
    Pushpa-Rajah JA; McLoughlin BC; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
    Schizophr Bull; 2015 Mar; 41(2):336-7. PubMed ID: 25552590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis and schizophrenia.
    McLoughlin BC; Pushpa-Rajah JA; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004837. PubMed ID: 25314586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
    Baker AL; Hides L; Lubman DI
    J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use and psychotic disorders: an update.
    Hall W; Degenhardt L; Teesson M
    Drug Alcohol Rev; 2004 Dec; 23(4):433-43. PubMed ID: 15763748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms].
    Jockers-Scherübl MC
    Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):533-43. PubMed ID: 17058779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does cannabis use lead to schizophrenia?].
    Heekeren K
    Praxis (Bern 1994); 2011 Nov; 100(22):1361-7. PubMed ID: 22048912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cannabis and psychosis--a review].
    Schaub M; Rössler W; Stohler R
    Praxis (Bern 1994); 2004 Jun; 93(23):997-1002. PubMed ID: 15233568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia and cannabis use.
    Kumra S
    Minn Med; 2007 Jan; 90(1):36-8. PubMed ID: 17305103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis, inhibitory neurons, and the progressive course of schizophrenia.
    Freedman R
    Am J Psychiatry; 2008 Apr; 165(4):416-9. PubMed ID: 18381910
    [No Abstract]   [Full Text] [Related]  

  • 10. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls.
    Dekker N; Smeerdijk AM; Wiers RW; Duits JH; van Gelder G; Houben K; Schippers G; Linszen DH; de Haan L
    Psychol Med; 2010 Aug; 40(8):1325-36. PubMed ID: 19917142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial.
    Barrowclough C; Marshall M; Gregg L; Fitzsimmons M; Tomenson B; Warburton J; Lobban F
    Psychol Med; 2014 Oct; 44(13):2749-61. PubMed ID: 25065535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.
    Sherman BJ; McRae-Clark AL; Baker NL; Sonne SC; Killeen TK; Cloud K; Gray KM
    Am J Addict; 2017 Mar; 26(2):136-144. PubMed ID: 28152236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When and How to Treat Possible Cannabis Use Disorder.
    Lévesque A; Le Foll B
    Med Clin North Am; 2018 Jul; 102(4):667-681. PubMed ID: 29933822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review.
    Hjorthøj C; Fohlmann A; Nordentoft M
    Addict Behav; 2009; 34(6-7):520-5. PubMed ID: 19268481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intervention efficacy in trials targeting cannabis use disorders in patients with comorbid psychosis systematic review and meta-analysis.
    Hjorthoj CR; Baker A; Fohlmann A; Nordentoft M
    Curr Pharm Des; 2014; 20(13):2205-11. PubMed ID: 23829367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review.
    Patel S; Khan S; M S; Hamid P
    Cureus; 2020 Jul; 12(7):e9309. PubMed ID: 32839678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based Treatment Options in Cannabis Dependency.
    Walther L; Gantner A; Heinz A; Majić T
    Dtsch Arztebl Int; 2016 Sep; 113(39):653-659. PubMed ID: 27776623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark.
    Hjorthøj C; Posselt CM; Nordentoft M
    JAMA Psychiatry; 2021 Sep; 78(9):1013-1019. PubMed ID: 34287621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review.
    Kondo KK; Morasco BJ; Nugent SM; Ayers CK; O'Neil ME; Freeman M; Kansagara D
    Ann Intern Med; 2020 Mar; 172(6):398-412. PubMed ID: 32120384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.